chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe pain across the front of her stomach/ rash/ shingles; severe pain in her head/it hurt to touch; severe pain in her head, it hurt to touch and had shocks and her whole body would cramp up; her whole body would cramp up; Tourette's; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198, expiration date: 30Jun2021) at the age of 71-years-old, via an unspecified route of administration in right shoulder on 05Mar2021 at 10:30 at single dose for COVID-19 immunization. Medical history included neuropathy in feet caused Tamoxifen (chemotherapy), anal cancer stage IV, breast cancer, double mastectomy, chemotherapy, and lymph node in left arm. Concomitant medications included gabapentin, meloxicam, and vitamins. There were no additional vaccines administered on the same date with the COVID-19 vaccine as well as within 4 weeks. The patient previously took tamoxifen as chemotherapy and experienced neuropathy in feet. The patient received her first COVID-19 vaccine on 05Mar2021 and on 13Mar2021, she experienced severe pain across the front of her stomach. On 19Mar2021, she said she has something, and it was a rash. She went to care facility on 20Mar2021 and was told she has shingles. The patient stated that the doctor just looked at her and said she has shingles, no testing was done. They told her it was ok for her to get the second shot, but she was worried about that. She experienced shingles since 13Mar2021, she still has it. She was supposed to have the shingles vaccine 4 years ago, but it was expensive. Her son heard on the radio that the shot may cause shingles, it may or may not be related but she wanted to let Pfizer know. The rash was starting to go away, and the pain was not, but the pain was far better. She ended up going to the doctor on 24Mar2021 with severe pain in her head since Mar2021, and she didn't know why. It hurt to touch and had shocks and her whole body would cramp up. Her daughter told her she looked like she had Tourette's, it was happening every 2-5 minutes. The doctor couldn't do anything and told her what she could take. It was an additional thing and the doctor said it was probably from shingles but she did not have a rash there. It was completely gone now. She received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727, expiration date: 31Jul2021), via an unspecified route of administration in right shoulder on 26Mar2021 at noon and stated that it was getting better then, and by 27Mar2021 it was gone completely. She was petrified this was going to happen while she was there to get the second vaccine and they would say she couldn't do it. The outcome of the event shingles was recovering and recovered on 27Mar2021 for all other events.
throbbing pain through both hands & feet;works itself out throughout the day-initial onset upon waking;
I tested positive for COVID-19 on 3/30/23. I had congestion, fever of 101, and fatigue. I was taking Tylenol for my fever. I contacted my doctor and was prescribed Paxlovid but decided not to fill it.  I am still dealing with these symptoms at this time.
vaccination site swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (vaccination site swelling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jun-2021, the patient experienced VACCINATION SITE SWELLING (vaccination site swelling). At the time of the report, VACCINATION SITE SWELLING (vaccination site swelling) outcome was unknown.            No concomitant medications was reported by the reporter. No treatment medications was  provided by the reporter.   Reporter did not allow further contact
nerve sensations on left calf; felt on my skin like it was being touched; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 21Jul2021 (Lot number: EW0196) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ischemic colitis", start date: 28Jan2019, stop date: 02Feb2019, notes: lack of Oxygen to colon caused Pain and bleeding colonoscopy biopsy determined Ischemic colitis; "Anti Depressant" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE taken for antidepressant therapy (ongoing). The following information was reported: LIMB DISCOMFORT (non-serious) with onset 21Jul2021, outcome "recovered" (24Jul2021), described as "nerve sensations on left calf"; PARAESTHESIA (non-serious) with onset 21Jul2021, outcome "recovered" (24Jul2021), described as "felt on my skin like it was being touched". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of limb discomfort, paraesthesia. Additional information: Prior vaccinations: None. Family medical history: N/A. Comments /Narrative: After 1st shot patient's left calf ankle Experienced weird Sensations felt like Someone was tickling patient of feather was rubbing against leg Definitely felt on patient's skin like it was being touched, but nothing was on patient's leg calf ( wearing Shorts ).  No follow-up attempts are possible. No further information is expected.
My heart went into atrial fibrillation.  I had a cardioversion  procedure at Hospital on January 10, 2021 and converted to normal sinus rhythm.  On January 19, 2022 my heat went back into atrial fibrillation.  I am scheduled for repeat cardioversion February 14,2022.
Extreme arm pain.  100.4 fever while on Tylenol.  Extreme fatigue.
FELT LIKE CRAP; UNABLE TO MOVE AND GET UP FOR WORK; NAUSEOUS; TERRIBLE HEADACHE; ACHE IN LEFT ARM WHERE VACCINE WAS GIVEN; DIZZY; CONFUSED; HARD TIME GETTING WORDS OUT; RAPID HEARTBEAT; ITCHING ON LEFT ARM AT VACCINATION SITE; ITCHING IN SCALP SHOULDER AREA AND WHOLE BACK; WHOLE BACK BURNING; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 16-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-AUG-2021, the patient experienced dizzy. On 16-AUG-2021, the patient experienced confused. On 16-AUG-2021, the patient experienced hard time getting words out. On 16-AUG-2021, the patient experienced rapid heartbeat. On 16-AUG-2021, the patient experienced itching on left arm at vaccination site. On 16-AUG-2021, the patient experienced itching in scalp shoulder area and whole back. On 16-AUG-2021, the patient experienced whole back burning. On 16-AUG-2021, the patient experienced nauseous. On 16-AUG-2021, the patient experienced terrible headache. On 16-AUG-2021, the patient experienced ache in left arm where vaccine was given. On 18-AUG-2021, the patient experienced felt like crap. On 18-AUG-2021, the patient experienced unable to move and get up for work. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nauseous, dizzy, confused, hard time getting words out, rapid heartbeat, terrible headache, ache in left arm where vaccine was given, itching on left arm at vaccination site, itching in scalp shoulder area and whole back, whole back burning, felt like crap and unable to move and get up for work was not reported. This report was non-serious.
Redness, warmth, raised red rash area, 2 to 3 inches surrounding the injection site, with induration, pain surrounding injection site.
Pt received flu shot 10am, called agency @2:10 pm. Stated had hives and itching.Hx ofBee sting allergy.went to see pt,hives on arms,upper chest,face and was diaphoretic,given 0.3cc epiSC,patient works in factory,worked with walnut wood for the first time day before,stated she had same S+S yesterday while working. Employer is now aware of the "walnut" issue.The rescue squad was called initially, at arrival 5 mins after epi dose her BP136/78, P 98.She refused  tx to Emerg Rm, Advised to take Benadryl when she  got home.She appeared stable when I left.   Pt received flu shot at her work site,given by a RN
Swelling, redness, pain in left arm. Dizzy, dry mouth, vomited, fainted, low B/P.
Posive COD Rapid test from a pharmacy 5/7/2021  sore throat, flu like symptomes elivated temperature
MA administered MMRV, instead of MMR, along with Varicella. Child received 2 doses of Varicella.
Patient reports 3 inch red rash which started 2 days after injection (live vaccines - side effects mimic natural infection) and feels like her entire arm will be consumed. She is in same pain and wants to consult with you.
Patient had severely sore arm and golf ball sized knot at injection site.  Very Painful, Very Itchy/  Still present after 3 days.  Rash, redness has spread to inside of arm/bicep
7/31/02 Swelling left arm. Went to ED. Rx with Keflex. 8/1/02 office visit follow up. Left ventral upper arm red, warm, positive induration about 13cm in circumference. No fever. Rx with Keflex 500 2 times, BID for 24 hours and follow up. 8/2 no redness. Still indurated and tender.
Arm swelled up and turned purple and red. On 9/4/02 at 8pm, there was a bump on his back of size of a dime. He ws covered with hives for the next two days. Difficulty breathing and fever.
bruising at the injection site; heat at the injection site; redness at the injection site; itching at the injection site; soreness at the injection site; headache; swelling at the injection site; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site), HEADACHE (headache), FATIGUE (tiredness), VACCINATION SITE BRUISING (bruising at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site), HEADACHE (headache) and FATIGUE (tiredness). On 21-Mar-2021, the patient experienced VACCINATION SITE BRUISING (bruising at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE PAIN (soreness at the injection site). On 21-Mar-2021, HEADACHE (headache) and FATIGUE (tiredness) outcome was unknown. At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE BRUISING (bruising at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE WARMTH (heat at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) had not resolved and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
This spontaneous prospective pregnancy report as received from a nurse practitioner refers to a female patient of unknown age. On 08-NOV-2013, the patient was vaccinated with MMR II and VARIVAX (Merck). No concomitant therapy was reported. The patient became pregnant with last menstrual period of 26-DEC-2013 and estimated delivery date of 02-OCT-2014. The patient had a qualitative HCG test on 03-FEB-2014 which showed that she was pregnant. The patient was seen by a physician on the same day. She also reported that the patient received ZOFRAN 4mg on 03-FEB-2014 for nausea. the outcome of the event was unknown. Additional information has been requested.
Dizziness, fatigue, nausea and vomiting, fever of 102. Felt very weak for 24. Dizziness remained after other symptoms resolved.
The morning after receiving the Johnson & Johnson Covid Vaccine I began to have dull pain in my testicles.  Not thinking much of it, I went along with my day only for the pain to continue into the evening.  That night when I went to take a shower  i noticed that my testicles were not only painful but slightly swollen. The pain and swelling continued until the third day in which the pain slightly decreased along with some of the swelling.  After about 5-7 days the pain was still periodically there (dull, sore pain) and the swelling was 90% gone. The issue continued for a few months until I visited my Primary Physician who wasn't sure about the issue but gave me an Antibiotic. The Antibiotic didn't change or fix the problem and the issue exists to this day.
My patient experienced diffuse urticaria and throat swelling. He was seen in the ER, given IV steroids and released as his symptoms improved after 2 days. He was discharged on Decadron and Benedryl.
Patient developed clinical pneumonia 5 days after receiving Flumist. Diagnosed by private medical doctor 12/24/03. Prescription Zithromax for 5 days. Medical record states asthenia. msv
Patient received 0.25 ml instead of 0.5 ml. Patient reported no symptoms but would follow up with doctor before receiving any more Covid vaccines.
Headache, fatigue, heavy limbs, neck and back ache, muscle cramps, stuffy nose. Currently experiencing symptoms.
Extreme shoulder pain in shoulder where vax was given that radiated across collar bones and to other shoulder. Felt flushed/hot all over. First episode was the night of administration and then 2 more times post administration.
Large localized reaction at site of vaccine injections (left thigh). Redness, swelling, warmth, and itching. Started approx. 24 hrs. after vaccination. Redness and swelling spread over next 24 hours. Redness approx. 8 x 10 cm in diameter. Parents applied ice and gave OTC CLARITIN. At visit on 11/1/2018, I prescribed diphenhydramine 12.5 mg/5 mL, give 2.5 mL every 4-6 hrs as needed for itch and swelling. Also notable: the Hepatitis A vaccine and DTaP vaccine given on 10/30/18 were extra, unnecessary vaccines. They were given in error because of lack of previous vaccination records. After the incident it was noted from past records that he had already received DTaP #4 and Hepatitis A #2. The patient also received the annual influenza vaccine in the right thigh, and this area also had a small localized reaction with redness and mild swelling of about 3-4 cm.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 08-OCT-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R015432, expiration date 15-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got discouraged to take 2nd dose / more than 36 days from first vaccination/ I never got my 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. Patient has stated that she did not experienced any events regarding first dose.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Updated Reporter's information. On 03-Aug-2021: Updated patient details.
what the dosing schedule is for the vaccine; what the dosing schedule is for the vaccine; the patient had a reaction and broke out in hives; the patient had a reaction and broke out in hives; This spontaneous report was received from a consumer (the patient's parent), referring to a 17-year-old female patient. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. It was reported that the patient had allergy to tree nuts.  On an unspecified date in 2017, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) route of administration reported as "injection" (dose, anatomical site of vaccination, lot number or expiration date were not reported) as the pediatrician recommended it (prophylaxis).  On the same day, the patient had a reaction and broke out in hives (urticaria and vaccination complication). The patient sought medical attention and went to the emergency room; as treatment she was administered an unspecified steroid. As soon as she received the steroid, the patient recovered from the events. The reporter wanted to know if "tree nut" could be in the vaccine components,  that could have caused the reaction; she also asked what the dosing schedule for the vaccine was (circumstance or information capable of leading to medication error and inappropriate schedule of product administration).  The causality assessment between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and the events urticaria and vaccination complication, was not reported.
After a few minutes of receiving vaccine, patient reported dizziness, light headedness, and blurry/dots in vision. She then became more upset leading to hyperventilation and crying. She then said she had tingling in her fingers, which progressed to difficulty moving her fingers/stiff fingers, and coldness and redness in tips of fingers. She then reported she was loosing sensations in her feet and legs. 911 was called. We tried to have the patient take slow deep breaths. We offered an ice pack and water up front and a heat pack for her fingers. Paramedics arrived. Her blood pressure, heart rate, oxygen saturation, glucose were within normal limits. She was given oxygen and the paramedic was able to help her slow her breathing. Her fingers went back to normal and she felt fine before leaving. She did not feel the need to go with the paramedics.
second dose given 23 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose given 23 days after first dose) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose given 23 days after first dose). On 22-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose given 23 days after first dose) had resolved.            Concomitant medication information not provided.  Treatment information not provided.
Itching swollen eyes recommended ocular lubricant and ketotifen, told patient to contact your office ASAP.
Since receiving the vaccine I've developed a food allergy or allergies.  Apparently, it's to one of the yellow dyes used in processed food.  I'm going to an allergist and will have the full set of "skin pricks" in August.  I've been prescribed an Epipen, which I keep nearby.
Client received his second dose of Pfizer vaccine and during the post-vaccination wait period in his work car, he complained of feeling nauseous. He denied any other symptoms. Vital signs: BP=116/78; Pulse=91. He was noted to be clammy. He was evaluated by the Nurse as well as the EMT Personnel on site, and declined for 911 to be called. He made arrangements for someone to give him a ride back home, and was instructed to call 911 if the nausea did not resolve. He voiced understanding and waited in his car until he was picked up.
Mild headache Woke up to really sore arm Chills Low grade fever of 100.5 F Had covid 3 months ago
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID in September 2022 for 3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2022, the patient experienced COVID-19 (COVID in September 2022 for 3 days). At the time of the report, COVID-19 (COVID in September 2022 for 3 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Reporter got COVID in Sep-2022 for 3 days and was negative and had mild symptoms.  No treatment information was provided.   Reporter did not allow further contact
Patient received first COVID vaccine dose on 2/25/21. She was given Moderna COVID vaccine. She was unable to  receive her 2nd dose at the 28 day mark because she contracted COVID 10 day after her first dose. She presented to our pharmacy on 7/23/21 asking for her 1st dose of Pfizer vaccine & it was administered. When she returned today for her 2nd dose, I saw on the database that she got a Moderna vaccine on 2/25/21. I asked patient about it and she confirmed. The second dose of the Pfizer vaccine was not administered. I explained that she had a completed series of mRNA vaccines even though she had two different manufacturers.  She reported no side effects to me after receiving her dose of Pfizer on 7/23/21.